As both chr7/17 gains tend to co-occur in pRCC, we also saw increased chr17 gene expression in non-ccRCC tumors, which was not observed in ccRCC (Figures 6H and S6F). This evidence concerns the gene PRCC and nonpapillary renal cell carcinoma.